PFE and NVO Related Headlines
Go Back- Trump to announce prescription drug price agreements
- UK and US poised to agree zero-tariffs deal on pharmaceuticals - The Times
- Bernstein on IRA pricing: $245 really is the floor
- Novo Nordisk shares rise on investor relief after it exits Metsera bid
- Novo CEO Says Bid For Metsera Is Higher Than Pfizer's Is Today
- Novo Nordisk Is Said To Sweeten Bid For Obesity Startup Metsera - Bloomberg
- Pfizer, Novo again raise Metsera bids in intensifying obesity drug battle
- Pfizer vows to continue Metsera legal fight after court denies restraining order
- Pfizer Preps Improved Offer In Metsera Bidding War - WSJ
- Pfizer Denied Temporary Block On Novo Nordisk’s Metsera Bid - Bloomberg
- Pfizer Drops Demand That Metsera Denounce Novo Bid: Metsera - Bloomberg
- FTC Says Novo-Metsera Bid Raises Merger Filing Concerns - Bloomberg
- Pfizer has removed conditions on sale of Arch Venture shares and Metsera public statements from its Metsera bid - Pfizer letter to court
- Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo
- Pfizer (PFE) CEO: our bid for Metsera has taken into consideration that prices of GLP-1 will probably start going down - Conference Call
- Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
- Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies - FT
- Metsera declares Novo Nordisk's $10 billion bid superior to Pfizer offer
- Novo Nordisk says Metsera bid won't raise antitrust issues
- Metsera responds to Pfizer litigation amid competing acquisition bids
- Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit
- Pfizer files second lawsuit against Novo Nordisk over Metsera acquisition
- Metsera responds to Pfizer litigation, will address claims in court
- Pfizer sues Metsera directors and Novo Nordisk over merger breach
- Pfizer gets early FTC clearance for Metsera acquisition
- Pfizer said to mull suing Novo Nordisk over Metsera bid
- Pfizer mulls suing Metsera, Novo Nordisk over topping bid - Semafor
- Metsera Was Previously in Exclusive Talks with Bristol-Myers Squibb, Sources Say -- WSJ
- Novo Nodrisk stock dips on aggressive odder to buy Metsera, 'reckless' says Pfizer
- Pfizer calls Novo Nordisk's Metsera bid reckless and illegal
- Pfizer Addresses Proposal for Metsera
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
